GSK : Analysis & Opinions

  1. Why is Pharma Struggling to Grow EPS?

    January 19, 2017
    GlaxoSmithKline announced a key change in its management structure. But there are other issues at play in the slow-growth ...
  2. In This Case Silence Could be Golden

    January 17, 2017
    Healthcare stocks are falling again ahead of Friday's transition of power.
  3. Ionis Has High Hopes for Heart Drug Volanesorsen

    January 13, 2017
    Ionis plans to file an FDA application for its heart drug volanesorsen after it did well in studies.
  4. Glaxo and Innoviva Get Positive News (GSK, INVA)

    December 2, 2016
    Glaxo and Innoviva are moving higher on the heels of positive news in both Europe and Japan for a COPD drug.
  5. How China Makes Money (BABA, PFE)

    December 2, 2016
    China has the first or second largest GDP in the world but is not nearly as developed as others in the top 10.
  6. GlaxoSmithKline Studies EPO-Like Anemia Drug (GSK)

    November 25, 2016
    The British pharma giant chases AstraZeneca to develop an anemia drug.
  7. GlaxoSmithKline Seeks FDA OK for COPD Inhaler (GSK)

    November 22, 2016
    Amid declining sales of its existing dual therapy inhaler, GSK pips rivals in filing for its triple therapy COPD product
  8. Half of Clinical Results Not Published (SNY, NVS)

    November 5, 2016
    Almost of all clinical trials are never published, and this hurts patients by withholding drug information.
  9. Defensive Investing: Learn from a Hedge Fund Pro

    August 31, 2016
    Looking for ideas on companies, sectors or investments to short? Consider the opinion of this hedge fund luminary.
  10. Zika Virus Vaccine Overturns Pharma Industry Playbook (GSK, SNY, ...

    August 28, 2016
    Big pharma has the funds and expertise necessary to develop a vaccine, but seems reluctant to.
  11. GlaxoSmithKline Trades Ex-Dividend Wednesday (GSK)

    August 9, 2016
    GlaxoSmithKline has a healthy pipeline of products to drive its Consumer Healthcare business in the quarters and years ahead.
  12. GlaxoSmithKline and Alphabet Partner to Start Bioelectronics ...

    July 31, 2016
    GSK will own 55% of the new entity while the remaining stake will be held by Verily Life Sciences.
  13. Brexit: GlaxoSmithKline Invests $361M in the UK (GSK)

    July 29, 2016
    Drugmaker GlaxoSmithKline is signaling confidence in the post-Brexit UK economy with plans to set up three new manufacturing ...
  14. The Impact of Novartis' New Business Model (NVS)

    May 23, 2016
    Amid the exit of its U.S. business head, Novartis is splitting its pharma business. Here's a look at what this split means ...
  15. Legal Risk Study: XLV, How Much Fines Have Component Companies ...

    May 8, 2016
    Learn the reasons behind the fines paid by the top three pharmaceutical companies held by XLV, and why they might not prevent ...
  16. J&J Loses Second Talcum Powder Cancer Case

    May 4, 2016
    A jury recently ordered Johnson & Johnson to pay $55 million in damages to a woman who claimed that its talcum powder ...
  17. Global Health Care Technology: 5 Key Industry Players (JNJ, GSK)

    April 27, 2016
    Discover how to analyze which of these top five key global health care technology industry players best suit your portfolio ...
  18. Is Big Pharma Under Pressure in 2016? (JNJ, GSK)

    March 8, 2016
    Find out why large pharmaceutical companies are coming under pressure by investors to break themselves up into smaller companies.
  19. How Novartis Probably Has a Cure for What Ails You

    January 21, 2016
    A look at the unparalleled growth of the world's biggest pharmaceutical company: Novartis AG.
  20. Why Biotech Affimed N.V. Should Be On Your Radar (JUNO, AFMD)

    December 8, 2015
    In the world of developmental biotech, picking the correct early stage companies can potentially make investors a fortune.
  21. The 5 Best Dividend Stocks in the Healthcare Sector (GSK, ABBV)

    October 7, 2015
    Learn about the top five dividend stocks of companies operating in the health care sector that generate substantial cash ...
  22. Glaxo in $1 Billion Ofatumumab Deal With Novartis (GSK, NVS)

    August 26, 2015
    In the latest deal between two pharmaceutical majors that clearly like doing business with each other, GlaxoSmithKline (NYSE: ...
  23. Make Room for Exelixis in Your Portfolio

    August 12, 2015
    Discover information and analysis on the biopharmaceutical company, Exelixis, and learn what makes it a good stock to consider ...
  24. Would Pfizer Buying GlaxoSmithKline Make Sense? (GSK, PFE)

    May 22, 2015
    Over the past five years, Pfizer (NYSE: PFE) and its shareholders have witnessed its stock price ascend by approximately ...
  25. Who are Gilead Sciences' (GILD) main competitors?

    May 22, 2015
    Learn about the pharmaceutical company Gilead Sciences and its main competitors. Explore the company's role in creating HIV-preventing ...
  26. 3 Top Pharma Stocks that Pay Regular Dividends (GSK, AZN)

    May 1, 2015
    The low down on three big name, dividend-paying pharma stocks.
  27. How the UK Makes Money

    April 29, 2015
    The United Kingdom has one of the strongest economies in the world thanks to the strength of its services, manufacturing ...
  28. The Future of Big Pharma Stocks

    March 31, 2015
    A look at the future health of big pharma stocks.
  29. Interested In Pharmaceutical Stocks? Try Novartis (ADR)

    February 26, 2015
    Novartis AG, is the world's leading pharmaceutical company by sales. Here is a closer look at Novartis, and how its financials ...
  30. The Best- and Worst-Performing Healthcare Stocks

    November 3, 2014
    Here are the best- and worst-performing stocks YTD in the healthcare sector with at least $2B in market cap and over 1 million ...
  31. Why There's Far More To Pfizer Than Viagra

    July 30, 2014
    Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, and not just because of that little ...
  32. European Stocks Are Ripe For The Picking

    February 26, 2014
    Things continue to get better for Europe. After going through some pretty nasty side-effects in the aftermath of the Great ...
  33. The United Kingdom Is Ripe For Stock Pickers

    December 6, 2013
    With the situation in Europe finally moving ahead, investors may want to focus on the United Kingdom. Stocks within the nation ...
  34. Big Pharma Faces 'Pay For Delay' Lawsuits

    June 21, 2013
    Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve never heard of pay to delay. Instead of ...
  35. The 5 Most Important Drugs In America

    July 28, 2009
    A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than others. ...